AU5970699A - Use - Google Patents
UseInfo
- Publication number
- AU5970699A AU5970699A AU59706/99A AU5970699A AU5970699A AU 5970699 A AU5970699 A AU 5970699A AU 59706/99 A AU59706/99 A AU 59706/99A AU 5970699 A AU5970699 A AU 5970699A AU 5970699 A AU5970699 A AU 5970699A
- Authority
- AU
- Australia
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9818914.5A GB9818914D0 (en) | 1998-08-28 | 1998-08-28 | Use |
| GB9818914 | 1998-08-28 | ||
| PCT/EP1999/006219 WO2000012623A2 (en) | 1998-08-28 | 1999-08-25 | Use of 5-th receptor antagonists for the treatment of parkinson's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5970699A true AU5970699A (en) | 2000-03-21 |
Family
ID=10838073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU59706/99A Abandoned AU5970699A (en) | 1998-08-28 | 1999-08-25 | Use |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5970699A (en) |
| GB (1) | GB9818914D0 (en) |
| WO (1) | WO2000012623A2 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4253126B2 (en) | 1998-01-29 | 2009-04-08 | アムジェン インコーポレイテッド | PPAR-gamma modulator |
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US6586592B2 (en) | 2000-06-20 | 2003-07-01 | Pharmacia & Upjohn Company | Bis-arylsulfones |
| PE20020063A1 (en) | 2000-06-20 | 2002-01-30 | Upjohn Co | BIS-ARYLSULFONES AS LIGANDS OF THE 5-HT RECEPTOR |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| JP3847711B2 (en) * | 2000-09-18 | 2006-11-22 | トーアエイヨー株式会社 | N-substituted benzothiophenesulfonamide derivatives |
| US7071220B2 (en) | 2000-09-18 | 2006-07-04 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
| MXPA03006250A (en) | 2001-01-16 | 2003-09-22 | Astrazeneca Ab | Therapeutic heterocyclic compounds. |
| IL156602A0 (en) | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic chromone compounds |
| US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
| PL366619A1 (en) * | 2001-05-11 | 2005-02-07 | Biovitrum Ab | Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| IL159880A0 (en) | 2001-08-10 | 2004-06-20 | Hoffmann La Roche | Arylsulfonyl derivatives with 5-ht6 receptor affinity |
| DE60333351D1 (en) * | 2002-03-15 | 2010-08-26 | Toa Eiyo Ltd | N-SUBSTITUTED BENZOTHIOPHENESULFONAMID DERIVATIVE |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| PA8802201A1 (en) * | 2007-11-02 | 2009-06-23 | Abbott Gmbh & Co Kg | APPROPRIATE BENCENSULFONALIDE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR |
| TWI465449B (en) | 2008-10-23 | 2014-12-21 | Vertex Pharma | Modulators of cystic fibrosis transmembrane conductance regulator |
| NZ595698A (en) | 2009-04-30 | 2014-01-31 | Abbvie Inc | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| US8343959B2 (en) | 2009-04-30 | 2013-01-01 | Abbott Gmbh & Co. Kg | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| EP2432770A1 (en) | 2009-04-30 | 2012-03-28 | Abbott GmbH & Co. KG | Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| JP2012525355A (en) * | 2009-04-30 | 2012-10-22 | アボット ゲーエムベーハー ウント カンパニー カーゲー | Benzenesulfonanilide compounds suitable for treating disorders responsive to modulation of serotonin 5-HT6 receptors |
| WO2012059432A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor |
| WO2012059431A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor |
| CN105636941A (en) * | 2013-10-25 | 2016-06-01 | 葛兰素史密斯克莱有限责任公司 | Novel compounds |
| AU2017256623B2 (en) * | 2016-04-26 | 2022-07-21 | H. Lundbeck A/S | Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in Parkinson's disease patients |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| DZ2376A1 (en) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them. |
| ATE296811T1 (en) * | 1997-07-11 | 2005-06-15 | Smithkline Beecham Plc | SULFONAMIDE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS AND METHOD FOR THE PRODUCTION THEREOF |
| GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
-
1998
- 1998-08-28 GB GBGB9818914.5A patent/GB9818914D0/en not_active Ceased
-
1999
- 1999-08-25 AU AU59706/99A patent/AU5970699A/en not_active Abandoned
- 1999-08-25 WO PCT/EP1999/006219 patent/WO2000012623A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000012623A2 (en) | 2000-03-09 |
| WO2000012623A3 (en) | 2000-08-24 |
| GB9818914D0 (en) | 1998-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3485999A (en) | Neo-tryptophan | |
| AU9392998A (en) | Pack-a-pillow | |
| AU5970699A (en) | Use | |
| AU3437799A (en) | City-car | |
| AU3522399A (en) | Carvedilol-galenics | |
| AUPP584198A0 (en) | New use | |
| AU5407599A (en) | Sphingolipid-desaturase | |
| AU3253699A (en) | Myxochelines | |
| AU8363398A (en) | Capotasto | |
| AU2609599A (en) | Sensor-coupling | |
| AU3204999A (en) | Futureball | |
| AU2069199A (en) | Codelets | |
| AU6235799A (en) | New use | |
| AU5223199A (en) | Bathtub-bathseat | |
| AU1055399A (en) | Rollerboard | |
| AU3347599A (en) | Aeromobile | |
| AU9347498A (en) | Imidazotriazolopyrimidines | |
| AU3819799A (en) | Methoximinomethyloxathiazines | |
| AU2840799A (en) | 1-phosphanorbornadienes | |
| AU4813399A (en) | New use | |
| AU9218098A (en) | Exocyclic-phosphoethanolamines | |
| AU1779099A (en) | Heterocyclyl-derivatives | |
| AU4768799A (en) | Bookcover | |
| AUPP505698A0 (en) | New use | |
| AUPP282798A0 (en) | New use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |